Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $3.25 $4.30 Thursday, 9th May 2024 GERN stock ended at $3.88. This is 1.84% more than the trading day before Wednesday, 8th May 2024. During the day the stock fluctuated 3.16% from a day low at $3.80 to a day high of $3.92.
90 days $1.64 $4.30
52 weeks $1.64 $4.30

Historical Geron Corporation prices

Date Open High Low Close Volume
Nov 25, 2016 $2.19 $2.24 $2.15 $2.23 469 827
Nov 23, 2016 $2.12 $2.20 $2.05 $2.19 951 578
Nov 22, 2016 $2.21 $2.23 $2.12 $2.15 943 951
Nov 21, 2016 $2.22 $2.23 $2.16 $2.19 806 981
Nov 18, 2016 $2.20 $2.21 $2.13 $2.19 1 067 090
Nov 17, 2016 $2.13 $2.22 $2.08 $2.19 971 328
Nov 16, 2016 $2.22 $2.22 $2.14 $2.15 1 300 094
Nov 15, 2016 $2.28 $2.28 $2.14 $2.22 1 280 725
Nov 14, 2016 $2.20 $2.26 $2.15 $2.26 1 677 397
Nov 11, 2016 $2.15 $2.22 $2.10 $2.20 2 085 504
Nov 10, 2016 $2.24 $2.27 $2.10 $2.14 2 450 058
Nov 09, 2016 $1.91 $2.18 $1.91 $2.18 3 345 061
Nov 08, 2016 $1.91 $1.93 $1.86 $1.89 988 904
Nov 07, 2016 $1.94 $1.97 $1.87 $1.92 1 487 700
Nov 04, 2016 $1.85 $1.98 $1.84 $1.90 2 144 700
Nov 03, 2016 $1.86 $1.89 $1.81 $1.81 1 330 000
Nov 02, 2016 $1.92 $1.94 $1.85 $1.85 1 159 600
Nov 01, 2016 $1.88 $1.95 $1.86 $1.93 1 367 200
Oct 31, 2016 $1.96 $1.96 $1.85 $1.85 1 575 700
Oct 28, 2016 $2.01 $2.02 $1.91 $1.96 1 632 700
Oct 27, 2016 $2.08 $2.09 $1.99 $2.01 1 147 500
Oct 26, 2016 $2.05 $2.14 $2.04 $2.06 1 071 400
Oct 25, 2016 $2.15 $2.15 $2.05 $2.07 1 153 500
Oct 24, 2016 $2.13 $2.18 $2.11 $2.14 913 200
Oct 21, 2016 $2.07 $2.14 $2.07 $2.12 1 189 300
Click to get the best stock tips daily for free!

About Geron Corporation

Geron Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hematologic myeloid malignancies for the treatment of low or intermediate-1 risk myelodysplastic syndromes a... GERN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT